These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4397068)

  • 21. Immunosuppression, virus and oncogenesis in mice.
    Nehlsen SL
    Transplant Proc; 1971 Mar; 3(1):811-3. PubMed ID: 4106340
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experimental and clinical administration of cytotoxic antilymphocyte serum and antilymphocyte globulin in homologous skin transplantation].
    Spasokukots'kii IuO; Gorodets'ka SF; Timoshenko IuG
    Fiziol Zh; 1971; 17(3):341-5. PubMed ID: 4118041
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antilymphocyte serum (ALS) as immunosuppressive agent].
    Piardi W
    Folia Allergol (Roma); 1971; 18(1):27-68. PubMed ID: 4397372
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of high doses of glucocorticoids on T-cell subsets in renal transplantation.
    Minetti L; Brando B; Civati G; Rovati C
    Adv Exp Med Biol; 1984; 171():345-51. PubMed ID: 6232834
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anti-thymocyte globulin for immunosuppression].
    Collste LG; Franksson C; Groth CG; Jacobson S; Magnusson G; Schantz B; Svehag SE; Werner B
    Nord Med; 1971; 86(46):1358. PubMed ID: 4944024
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 27. The immunosuppressive activity of ara-C (cytarabine) and derivatives.
    Gray GD
    Transplant Proc; 1973 Sep; 5(3):1203-9. PubMed ID: 4147026
    [No Abstract]   [Full Text] [Related]  

  • 28. The mixed leukocyte response in human renal transplantation.
    Shons AR; Etheredge EE; Schmidtke JR; Najarian JS
    Transplant Proc; 1973 Mar; 5(1):337-42. PubMed ID: 4266657
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
    Cerilli GJ; Miller A; Hattan D
    Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone marrow chimeras in man and animals.
    Thomas ED; Storb R; Epstein RB
    Hamatol Bluttransfus; 1970; 9():86-95. PubMed ID: 4396279
    [No Abstract]   [Full Text] [Related]  

  • 31. The immunological status of rats with long surviving (enhanced) kidney allografts.
    Mullen Y; Takasugi M; Hildemann WH
    Transplantation; 1973 Feb; 15(2):238-46. PubMed ID: 4146170
    [No Abstract]   [Full Text] [Related]  

  • 32. The efficiency of sheep antidog antilymphocyte serum (SADALS) in the prolongation of canine heart allografts.
    Halpern B; Cachera JP; Lacombe M; Hathaway A; Crepin Y; Hung BM; Lacassagne JP; Leandri J; Laurent D; Dubost C; de Mendoza M
    Transplant Proc; 1969 Mar; 1(1):467-9. PubMed ID: 4944261
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical transplantation--an overview.
    Kountz SL
    Transplant Proc; 1973 Mar; 5(1):59-65. PubMed ID: 4572118
    [No Abstract]   [Full Text] [Related]  

  • 34. Prolongation of canine renal homograft survival by post-transplantation treatment with antithymocyte serum.
    Hinchey EJ; Bliss JQ
    Ann Surg; 1970 Apr; 171(4):543-52. PubMed ID: 4392297
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of immunosuppressive agents and matching on pulmonary allografts.
    Motlagh FA; Dutta SK; Paley N; Karlson KE; Garzon AA
    Surg Forum; 1970; 21():196-8. PubMed ID: 4936968
    [No Abstract]   [Full Text] [Related]  

  • 36. Preliminary studies on antithymocyte globulin.
    Orlowski T; Skopińska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 37. The clinical use of antilymphocyte globulin in renal homotransplantation.
    Starzl TE; Marchioro TL; Hutchinson DE; Porter KA; Cerilli GJ; Brettschneider L
    Transplantation; 1967 Jul; 5(4):Suppl:1100-5. PubMed ID: 4167452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the properties of skin allografts on the "graft survival promoting effect" of antilymphocyte serum.
    Nouza K; Nêmec M; Viklický V; Novotný J
    Folia Biol (Praha); 1976; 22(2):74-81. PubMed ID: 6347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The future of constructive surgery.
    Russell PS
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):147-52. PubMed ID: 4612900
    [No Abstract]   [Full Text] [Related]  

  • 40. Antilymphocyte serum and the induction of tolerance to transplantation antigens.
    Lance EM; Medawar PB
    Fed Proc; 1970; 29(1):151-2. PubMed ID: 4391648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.